Gribo Cold

Description

GRİBO COLD is a pharmaceutical preparation available in PVC/aluminium foil blister packs containing 10, 24, or 30 tablets, formulated with the active ingredients ibuprofen and pseudoephedrine. Ibuprofen, a non-steroidal anti-inflammatory drug (NSAID), provides analgesic and antipyretic effects, while pseudoephedrine acts as a decongestant, alleviating nasal and sinus congestion.

Gribo COLD 200 mg/30 mg tablet Taken orally.

Active ingredients : Each tablet contains 200 mg of Ibuprofen and 30 mg of Pseudoephedrine hydrochloride.

Auxiliary substances : Microcrystalline cellulose, modified corn starch, colloidal silicon dioxide, sodium starch glycolate, stearic acid.

Read this article carefully before starting to use this drug. Because it contains very important information for you.

• Keep this instructions for use. You may need to read again later.
• If you have any additional questions, please consult your doctor or pharmacist.
• This drug is personally prescribed for you, do not give it to others. Even if other people’s symptoms are the same as yours, the drug can harm them.
• During the use of this drug, when you go to the doctor or hospital, tell your doctor that you are using this drug.
• Follow the instructions in this instruction.

DO NOT use GRİBO COLD in the following cases

Risks associated with the cardiovascular system

– it may cause an increased risk of potentially fatal thrombolic events, heart attacks and strokes. This risk may increase depending on the duration of use. Patients with cardiovascular disease or cardiovascular disease risk factors may have a higher risk.

– GRIBO COLD coronary artery should not be used in the treatment of pain before “bypass” surgery.

Precautions and Warnings When Using GRİBO COLD

GRİBO COLD is a medication used to manage symptoms such as pain, fever, and inflammation, especially in respiratory tract infections. While effective, its use is associated with various risks that necessitate careful consideration before and during treatment. This guide outlines specific risks, contraindications, and precautions to help ensure safe usage.

Gastrointestinal Risks

GRİBO COLD may cause serious gastrointestinal complications, including bleeding, scarring, ulcers, and intestinal perforations. These effects can be fatal and may occur without prior warning symptoms. Elderly patients are particularly vulnerable to these adverse outcomes. If gastrointestinal symptoms such as stomach pain, dark stools, or vomiting of blood appear, discontinue use immediately and consult your doctor.

Individuals with existing gastrointestinal conditions like ulcers or inflammatory bowel diseases (e.g., Crohn’s disease, ulcerative colitis) should only use the drug under strict medical supervision, often in conjunction with protective agents such as proton pump inhibitors or misoprostol.

Absolute Contraindications

GRİBO COLD may cause severe allergic reactions, including facial and throat swelling, difficulty breathing, bronchospasm, and skin reactions like exfoliation or mucosal damage. These require immediate discontinuation and medical evaluation. Spontaneous bruising or skin discoloration may also indicate underlying blood disorders.

Neurological Complications

Sudden onset of chills, fever, vomiting, headache, weakness, and neck stiffness during treatment may be signs of aseptic meningitis, a serious condition requiring urgent medical intervention.

Renal and Hepatic Considerations

Patients with kidney disease should use GRİBO COLD with caution, as it may impair renal function. Liver enzyme elevations may occur, and signs of hepatic dysfunction such as jaundice, fatigue, nausea, and abdominal pain should prompt immediate medical attention.

Hematological Effects

GRİBO COLD can inhibit platelet aggregation, leading to increased bleeding risk. Patients with clotting disorders should use it only under medical supervision. Unexplained bruising or bleeding should be investigated promptly.

Ophthalmologic Effects

Visual disturbances during treatment require an ophthalmologic evaluation to rule out medication-related complications.

Cardiovascular Risks

The drug should be used cautiously in individuals with high blood pressure or heart failure due to the risk of fluid retention. GRİBO COLD may increase the risk of serious cardiovascular events such as heart attacks and strokes, even without prior symptoms. Warning signs include chest pain, difficulty breathing, sudden weakness, and speech problems.

Elderly and Long-Term Use Precautions

GRİBO COLD should not be used for more than five consecutive days. Patients over 60 years old are at greater risk for serious gastrointestinal complications, including bleeding and perforation.

Other Special Populations

Caution is advised in patients with prostate enlargement or urinary retention, as well as those with systemic lupus erythematosus (SLE), an autoimmune connective tissue disorder. Athletes should note that GRİBO COLD may cause false-positive doping results.

Pseudoephedrine-Related Reactions

GRİBO COLD contains pseudoephedrine, which can rarely trigger sudden abdominal pain, nausea, vomiting, and visual disturbances. If these symptoms occur, treatment must be stopped immediately.

Heart Rhythm Disorders

Patients diagnosed with or suspected of having prolonged QT syndrome or Torsades de Pointes—a life-threatening heart arrhythmia—should use GRİBO COLD with extreme caution, as it may aggravate these conditions.

Use of GRIBO COLD with food and drink

Its interaction with food and beverages has not been reported.

Pregnancy

Consult your doctor or pharmacist before using the drug.

Gribo cold should not be used during pregnancy.

If you find that you are pregnant during your treatment, consult your doctor or pharmacist immediately.

Lactation

Consult your doctor or pharmacist before using the drug.

Although it is known that ibuprofe passes into breast milk in very small amounts, pseudoefedrin passes in a significant amount to breast milk.

Gribo cold should not be used during breastfeeding.

Vehicle and machine use

Do not use vehicles or machines as dizziness may develop during the use of GRİBO COLD.

Some of the auxiliary substances contained in GRİBO COLD

No warning is required for any of the auxiliary substances contained in the content due to the way or dose of use.

Drug Interactions with GRİBO COLD

The concurrent use of GRİBO COLD with other medications may lead to reduced therapeutic efficacy or increased risk of serious side effects. Therefore, it is important to evaluate potential drug interactions before initiating treatment, and patients should always inform their healthcare provider of all medications they are currently taking or have recently used, including prescription drugs, over-the-counter products, and herbal supplements.

Impact on Blood Pressure and Cardiovascular Medications

GRİBO COLD contains pseudoephedrine, which may counteract the effects of blood pressure-lowering medications such as bretylium, betanidine, guanethidine, debrisoquine, methyldopa, and alpha or beta adrenergic blockers. This interaction can result in elevated blood pressure. Additionally, ibuprofen—an anti-inflammatory component in GRİBO COLD—may reduce the antihypertensive effects of drugs used for managing hypertension and may increase the nephrotoxic risk when combined with ACE inhibitors or diuretics such as furosemide and thiazides.

Increased Risk of Bleeding

The combination of GRİBO COLD with anticoagulants such as warfarin or heparin may potentiate anticoagulant activity, raising the risk of bleeding. Similarly, concurrent use with antiplatelet agents like aspirin, dipyridamole, or clopidogrel, or with selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine, paroxetine, or sertraline, increases the likelihood of gastrointestinal bleeding.

Interactions with Other NSAIDs and Corticosteroids

Use of GRİBO COLD alongside other nonsteroidal anti-inflammatory drugs (NSAIDs), including COX-2 inhibitors such as celecoxib and nimesulide, should be avoided due to the compounded risk of gastrointestinal ulceration and bleeding. The same risk is elevated when the drug is taken with corticosteroids.

Effects on Renal Function and Nephrotoxicity Risk

When used with nephrotoxic antibiotics like aminoglycosides (e.g., gentamicin, kanamycin, streptomycin), the risk of kidney toxicity may increase due to decreased renal excretion. Similar risks arise when GRİBO COLD is combined with immunosuppressive agents like cyclosporine or tacrolimus.

Reduced Efficacy or Altered Drug Levels

GRİBO COLD may delay the effect of cholestyramine, a bile acid-binding resin. It may also reduce the effectiveness of mifepristone if taken within a short time frame. Conversely, it can increase plasma concentrations and toxicity of certain drugs such as methotrexate (used in cancer and autoimmune conditions) and lithium (used in psychiatric disorders).

Central Nervous System and Psychiatric Medication Interactions

Concomitant use with tricyclic antidepressants (e.g., amitriptyline, nortriptyline, imipramine), monoamine oxidase inhibitors (e.g., moclobemide), or other central nervous system stimulants may lead to elevated blood pressure or hypertensive crises. These effects are attributed to pseudoephedrine’s sympathomimetic action, which may antagonize the effects of sedatives or intensify stimulant effects.

Antibiotics and Antiretroviral Drug Interactions

When GRİBO COLD is used with quinolone antibiotics such as ciprofloxacin, the risk of seizures (convulsions) may increase. It may also enhance the hematologic toxicity of zidovudine, a medication used in HIV treatment.

Risk in Migraine and Labor Medications

Using GRİBO COLD in conjunction with ergot alkaloids (e.g., ergotamine, methysergide), typically prescribed for migraines, increases the risk of vasoconstriction and associated side effects. Likewise, when combined with oxytocin, used to induce labor, there may be an increased risk of hypertension.

Interaction with Hypoglycemic Agents

Rare cases of hypoglycemia have been observed when GRİBO COLD is used alongside sulfonylureas, a class of drugs used in the treatment of diabetes. Blood sugar levels should be closely monitored when these drugs are taken together.

CYP2C9 Inhibitors and Drug Metabolism

The metabolic clearance of ibuprofen may be altered when GRİBO COLD is used in combination with CYP2C9 inhibitors such as fluconazole or voriconazole. A dose adjustment of ibuprofen may be necessary in such cases to avoid toxicity.

How to Use GRİBO COLD

For adults and children over 12 years of age, GRİBO COLD should be taken orally with a sufficient amount of water. The initial dose is 2 tablets, followed by 1–2 tablets every 4 hours as needed. Do not exceed 6 tablets in a 24-hour period, unless otherwise directed by a physician. To minimize the risk of side effects, use the medication at the lowest effective dose for the shortest duration necessary.

Method of Administration

GRİBO COLD is administered orally and should be swallowed with a glass of water.

Use in Different Age Groups

Children

GRİBO COLD is not recommended for children under 12 years of age.
For children 12 years and older, the adult dosage applies.

Elderly

The adult dosage also applies to elderly patients. However, extra caution is advised in those over 60 years of age, due to an increased risk of side effects.

Special Considerations

Use of GRİBO COLD should be avoided in patients with severe kidney or liver failure. If deemed necessary, the medication should only be used under medical supervision and at the lowest effective dose.

In Case of Overdose

If more GRİBO COLD than recommended is used—either accidentally or intentionally—immediate medical attention is required. Seek help from a doctor or the nearest hospital.

Possible Symptoms of Overdose:

• Nausea, abdominal pain, vomiting (possibly with blood)

• Headache, tinnitus, blurred consciousness

• Shaky eye movements, drowsiness

• Chest pain, palpitations, convulsions (especially in children)

• Loss of consciousness, weakness, dizziness

• Blood in urine, cold sensation, breathing difficulties

Missed Dose

If a dose is missed, do not take a double dose to compensate. Simply continue with the next scheduled dose as directed.

Conclusion

GRİBO COLD should be used exactly as prescribed, with close attention to dosage limits, age restrictions, and health conditions such as liver or kidney impairment. Always consult your doctor or pharmacist if unsure about the correct usage or if side effects occur. Proper adherence ensures both the safety and effectiveness of the treatment.